Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Conditions

Endometrial Neoplasms 6 Lymphatic Metastasis 4 Uterine Cervical Neoplasms 3 Urinary Bladder Neoplasms 3 Breast Neoplasms 3 Stomach Neoplasms 2 Prostatic Neoplasms 2 Neoplasm Metastasis 2 Lung Neoplasms 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Clinical Stage I Gastric Cancer AJCC v8 2 Carcinoma, Transitional Cell 2 Vulvar Neoplasms 1 Urologic Neoplasms 1 Ureteral Neoplasms 1 Recurrence 1 Radiation Injuries 1 Prostate Adenocarcinoma 1 Postoperative Complications 1 Ovarian Neoplasms 1 Neoplastic Cells, Circulating 1 Neoplasms 1 Mixed Tumor, Mesodermal 1 Melanoma 1 Lymphedema 1 Gallbladder Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Disease 1 Cholangiocarcinoma 1

Interventions

Paclitaxel 326 Carboplatin 318 Bevacizumab 167 Gemcitabine 106 pembrolizumab 100 liposomal doxorubicin 100 Cyclophosphamide 94 Topotecan 93 Cisplatin 89 olaparib 86 niraparib 60 Docetaxel 56 Taxes 52 Doxorubicin 50 Drug Therapy 42 fludarabine 39 Filgrastim 39 Nivolumab 37 Etoposide 32 Specimen Handling 31 Magnetic Resonance Spectroscopy 29 Immunoglobulin G 27 Disulfides 27 Peripheral Blood Stem Cell Transplantation 26 Albumin-Bound Paclitaxel 25 durvalumab 24 aldesleukin 24 Hyperthermic Intraperitoneal Chemotherapy 24 Oxaliplatin 23 Biopsy 21

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Ovarian Neoplasms × Lymph Node Excision × Clear all

NCT00712218 2020-03-04

LION

Philipps University Marburg

Phase NA Completed

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡